In addition, the level of mtDNA was significantly higher in the relapse phase of NMOSD than in that of MS (COX3: p = 0.044; ND1: p = 0.042; ND6: p = 0.018) (Fig. 1a–c). This evidence concerns the gene MT-ND6 and myeloid sarcoma.